NRIX vs PAYX · rev $54.5M vs P/E 22, rev $5.57B
Nurix Therapeutics Inc (NRIX) versus Paychex Inc (PAYX) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
Latest reported PAYX revenue for 2025-05-31 was $5.57B. Net income was $1.66B. Revenue was up 5.6% from 2024-05-31 to 2025-05-31. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
NRIX currently screens at market cap $1.77B. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
Not investment advice. Open the NRIX and PAYX stock pages for the full models.
Not investment advice.